Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07689331

Hungarian National Systemic Amyloidosis Registry

Conditions: Systemic Amyloidosis, ATTR Amyloidosis, AL Amyloidosis, Amyloid Cardiomyopathy

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 300

Sponsor: Semmelweis University

Location: Balatonfüredi Állami Szívkórház Balatonfüred

Summary

This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of systemic amyloidosis * Patients aged ≥18 years at the time of enrollment * Signed informed consent form by the patient * Treating physician's consent * Availability of accessible medical history Exclusion Criteria: * Lack of informed consent in the prospective study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07689331). StuddyBuddy aggregates publicly available trial information.